Discover & Validate Novel Predictive Biomarkers
Improve Your Selection of Patient Responders
Effectively Deliver Diagnostic-Enabled Therapies to Market
Now in its 8th year, World CDx Boston remains committed to helping large pharma and biotech apply an effective biomarker and diagnostic strategy. By improved selection of responders vs non-responders, simultaneously accelerate and de-risk your drug development timeline of precision medicines for both oncology and non-oncology indications.
Be part of focused, disruptive and candid discussions that need to take place if more safe, effective and targeted drug candidates are to be approved, reimbursed and adopted by the intended patient population.
We are currently building the agenda and speaker faculty for this years meeting. To stay in the loop and be the first to receive the 2017 agenda, please register your interest here.
“World CDx was a fantastic event both in terms of the science and the networking opportunities."
- Oscar Puig, Biomarker Leader, Oncology, Roche